News Camurus AB

Equities

CAMX

SE0007692850

Market Closed - Nasdaq Stockholm Other stock markets 06:59:57 2024-04-30 am EDT			5-day change	1st Jan Change
498.2 ^SEK	+0.36%		+4.88%	-7.40%

Apr. 17	Certain Shares of Camurus AB are subject to a Lock-Up Agreement Ending on 17-APR-2024.	CI
Apr. 02	Camurus AB Announces Board Resignations	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Certain Shares of Camurus AB are subject to a Lock-Up Agreement Ending on 17-APR-2024.	Apr. 16	CI
Notice of annual general meeting 2024 in Camurus (publ)	Apr. 02	AQ
Camurus AB Announces Board Resignations	Apr. 02	CI
Camurus Annual Report for 2023	Mar. 28	AQ
Camurus' New Drug Application for Acromegaly Treatment Accepted by US FDA	Mar. 05	MT
Camurus announces FDA acceptance of NDA submission for Oclaiz™ for treatment of acromegaly	Mar. 05	AQ
Camurus AB Announces FDA Acceptance of NDA Submission for Oclaiz? for Treatment of Acromegaly	Mar. 05	CI
Camurus AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Nordic Shares Rose Thursday; Tomra Systems Climbed Highest	Feb. 15	DJ
Transcript : Camurus AB, 2023 Earnings Call, Feb 15, 2024	Feb. 15
Camurus' Full Year Report 2023	Feb. 15	AQ
Camurus AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Camurus AB Provides Earnings Guidance for the Full Year 2024	Feb. 15	CI
Camurus appoints Behshad Sheldon as President of Camurus Inc.	Feb. 13	AQ
Camurus AB Appoints Behshad Sheldon as President of Camurus Inc. and Member of the it's Executive Management Team, Starting 1 April 2024	Feb. 13	CI
Completed enrollment in the POSITANO study of CAM2029 in patients with polycystic liver disease	Feb. 08	AQ
Camurus AB Completes Enrollment in the POSITANO Study of CAM2029 in Patients with Polycystic Liver Disease	Feb. 08	CI
Nordic Stocks Rose Thursday; Kinnevik Series B Topped Leaders	Jan. 18	DJ
Camurus has carried out a directed share issue of 2,000,000 shares at a subscription price of SEK 545 per share, raising gross proceeds of SEK 1,090 million	Jan. 17	AQ
Camurus intends to carry out a directed share issue of approximately 2 million shares and provides preliminary financial information for FY 2023	Jan. 17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Camurus AB

Equities

CAMX

SE0007692850

Summary

Filters